financetom
Business
financetom
/
Business
/
Alkane And Mandalay Combine In A $707 Million 'Merger Of Equals'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alkane And Mandalay Combine In A $707 Million 'Merger Of Equals'
May 25, 2025 10:12 PM

Australia's Alkane Resources ( ALKEF )   and Canada's Mandalay Resources ( MNDJF )   have announced a "merger of equals "in an all-share transaction valued at approximately AU$1.01 billion ($707 million), creating a diversified gold and antimony producer with global reach.

The newly combined company will retain the Alkane name and remain listed in Australia, but it will seek a dual listing on the Toronto Stock Exchange.

"The transaction will take Alkane to a new level, bringing together two companies with complementary assets and a shared vision for growth," said Nick Earner, Alkane Managing Director. "Mandalay's two high-quality mines match the attributes of Tomingley: a proven history of consistent production, cash generation and exploration upside."

The merger brings together three producing assets across premier mining jurisdictions. Alkane contributes to the Tomingley gold mine in New South Wales, which is currently ramping up production after an expansion.

Mandalay adds its Costerfield gold-antimony mine in Victoria—Australia's only antimony producer—and the Björkdal underground gold mine in Sweden.

The combined group is projected to produce approximately 160,000 gold-equivalent ounces in 2025, increasing to over 180,000 ounces in 2026. Additionally, all-in sustaining costs (AISC) are forecast to drop from AU$2,750/oz in 2025 to AU$2,160/oz in 2026, reflecting improved scale and efficiency.

Frazer Bourchier, Mandalay's President and CEO, noted the merger "presents a compelling opportunity for Mandalay shareholders to accelerate value creation through increased capital markets scale, liquidity and a growing diversified asset base."

"The transaction aligns with our vision to create a mid-tier gold and antimony producer with mines in premier operating jurisdictions and with our strategy for continued growth," he said.

Alkane's Earner will lead the new entity, headquartered in Australia, while industry veteran Andrew Quinn will lead the board, which comprises three directors nominated by Mandalay and two by Alkane.

The pro forma balance sheet includes a robust cash position of AU$188 million ($120 million) as of March 31, 2025, allowing it to pursue further organic growth and strategic opportunities, including advancing Alkane's Boda-Kaiser copper-gold project.

Mandalay shareholders will receive 7.875 Alkane shares for each share they hold, resulting in a 55% stake in the new company, while Alkane shareholders will retain 45%. The transaction has the unanimous support of both boards and major shareholders and is subject to regulatory, shareholder, and court approvals.

The companies expect the deal to close in the second half of 2025, pending regulatory approvals.

Read Next:

KoBold Metals Prepares Billions To Develop Ethical Sources Of Critical Metals In DR Congo

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US startup Lyten to buy troubled European battery maker Northvolt
US startup Lyten to buy troubled European battery maker Northvolt
Aug 7, 2025
* Silicon Valley startup Lyten buys Northvolt for an undisclosed sum * Lyten CEO expects battery cell deliveries to resume in 2026 * Deal includes Northvolt's projects in Sweden and Germany By Marie Mannes STOCKHOLM, Aug 7 (Reuters) - U.S. battery startup Lyten has agreed to buy most of bankrupt Swedish battery maker Northvolt, it said on Thursday, potentially offering...
Akebia Therapeutics Shares Fall After Reporting Q2 Results
Akebia Therapeutics Shares Fall After Reporting Q2 Results
Aug 7, 2025
10:00 AM EDT, 08/07/2025 (MT Newswires) -- Akebia Therapeutics ( AKBA ) shares were down more than 17% in early Thursday trading after the company reported breakeven Q2 net income, swinging from a loss of $0.04 per share a year earlier. Analysts polled by FactSet expected a loss of $0.02. Revenue for the quarter ended June 30 was $62.5 million,...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Paxos Trust reaches $48.5 million settlement with New York related to Binance
Paxos Trust reaches $48.5 million settlement with New York related to Binance
Aug 7, 2025
NEW YORK (Reuters) -Paxos Trust reached a $48.5 million settlement to resolve New York charges it failed to conduct sufficient due diligence of its former partner Binance, and had systemic failures in its anti-money laundering program, the state's financial services regulator said on Thursday. The settlement calls for Paxos to pay a $26.5 million fine and spend $22 million to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved